Maryland Bill Would Allow Veterinarians to Recommend Cannabis for Pets
Affiliate Disclosure: This article contains affiliate links. CBDworldnews.com may earn a commission on qualifying purchases at no additional cost to you.
Every day, pet owners across Maryland walk into stores and buy CBD products for their dogs and cats—no prescription, no professional guidance, no safety net. Their veterinarians, the one professionals qualified to advise them, are legally barred from saying a word about it. A new Maryland bill aims to end that contradiction, and the CBD for pets industry is watching closely.
Maryland lawmakers are advancing legislation in the 2026 legislative session that would permit licensed veterinarians to recommend cannabis and CBD products to pet owners—a move that could fundamentally reshape how vets advise clients in a rapidly growing market currently operating without meaningful professional medical oversight. The bill cuts to the heart of a quiet crisis: pet owners are already spending heavily on these products, yet the experts best positioned to guide them are forced to stay silent.
The legal paradox the bill addresses is striking. While pet owners can legally purchase CBD products in most states, veterinarians risk professional discipline or license suspension for even discussing cannabis options with clients. According to reporting by the Baltimore Business Journal, the measure would remove that restriction, allowing vets to provide recommendations based on clinical judgment. Most state veterinary boards currently classify cannabis discussion as practicing medicine without DEA approval—even in states where the products sit openly on retail shelves.
Maryland’s proposal seeks to carve out explicit legal protection for licensed practitioners, giving them the latitude to apply professional judgment where consumer demand already exists.
The legislation draws support from emerging—if still early—research. Colorado State University has published preliminary findings suggesting CBD may have relevance for pain management and mobility support in dogs, offering an evidence base for professional consideration. That said, the science remains nascent, and it is important to state clearly: no CBD or cannabis products for pets have received FDA approval, and the agency has not established safety or efficacy standards for animal use. Veterinarians and pet owners alike should weigh that regulatory reality before making any treatment decisions.
Maryland’s effort reflects a broader national shift. Multiple states are considering or have passed similar veterinary-recommendation measures in 2026, signaling mounting pressure from pet owners, advocacy groups, and industry stakeholders to integrate cannabis products into conventional veterinary practice. The pattern reveals a fundamental gap: consumers are already purchasing these products without professional guidance, creating urgent demand for exactly the kind of expert counsel veterinarians are currently prohibited from providing.
Industry observers see the legislation as a meaningful pathway to legitimacy and improved consumer safety. If veterinarians can openly evaluate, discuss, and recommend products, market transparency is likely to improve and more rigorous consumer safety frameworks may begin to take shape around animal use. Regulatory bodies remain appropriately cautious, however—balancing a wave of innovation against the continued absence of formal FDA oversight for animal cannabis products.
The Verdict: This bill matters well beyond Maryland’s borders. Pet owners are not waiting for regulatory clarity—they are already buying CBD products for their animals by the millions, often with no idea whether what they are purchasing is safe, appropriately dosed, or relevant to their pet’s condition. Allowing veterinarians to enter that conversation does not create risk; it reduces it. If Maryland passes this measure, it will not simply be a win for one state’s pet owners—it will establish a replicable model for responsible, professionally guided cannabis use in veterinary medicine at a moment when the rest of the country desperately needs one. The question is no longer whether pet owners will use these products. The question is whether a licensed expert will be allowed to help them do it safely.
This article is for informational purposes only. Nothing on CBDworldnews.com constitutes medical or veterinary advice. These statements have not been evaluated by the Food and Drug Administration. CBD and cannabis products are not intended to diagnose, treat, cure, or prevent any disease or medical condition in humans or animals. Always consult a licensed veterinarian before making health decisions for your pet.
